SUMATRIPTAN SUCCINATE Drug Patent Profile
✉ Email this page to a colleague
When do Sumatriptan Succinate patents expire, and what generic alternatives are available?
Sumatriptan Succinate is a drug marketed by Antares Pharma Inc, Baxter Hlthcare Corp, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Hikma, Mylan Labs Ltd, Par Pharm, Par Sterile Products, Sandoz, Somerset, Steriscience, Sun Pharm, Teva Parenteral, Teva Pharms Usa, West-ward Pharms Int, Wockhardt, Zydus, Aurobindo Pharma, Corepharma, Dr Reddys Labs Inc, Fosun Pharma, Hikma Pharms, Mylan, Orbion Pharms, Roxane, Sun Pharm Inds, Sun Pharm Inds Ltd, Teva, and Watson Labs. and is included in thirty-four NDAs.
The generic ingredient in SUMATRIPTAN SUCCINATE is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sumatriptan Succinate
A generic version of SUMATRIPTAN SUCCINATE was approved as sumatriptan succinate by WEST-WARD PHARMS INT on February 6th, 2009.
Summary for SUMATRIPTAN SUCCINATE
US Patents: | 0 |
Applicants: | 30 |
NDAs: | 34 |
Finished Product Suppliers / Packagers: | 30 |
Raw Ingredient (Bulk) Api Vendors: | 116 |
Clinical Trials: | 26 |
Patent Applications: | 2,369 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SUMATRIPTAN SUCCINATE |
What excipients (inactive ingredients) are in SUMATRIPTAN SUCCINATE? | SUMATRIPTAN SUCCINATE excipients list |
DailyMed Link: | SUMATRIPTAN SUCCINATE at DailyMed |
Recent Clinical Trials for SUMATRIPTAN SUCCINATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Jiangsu Provincial People's Hospital | Phase 3 |
West China Hospital | Phase 3 |
The Second Affiliated Hospital of Kunming Medical University | Phase 3 |
Pharmacology for SUMATRIPTAN SUCCINATE
Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |